ABSTRACT We recorded a discrete 0.95 mV potential consistent with accessory atrioventricular pathway (AP) activation during serial electrophysiologic studies in a patient with Ebstein's anomaly and Wolff-Parkinson-White syndrome. Bipolar pacing from the catheter electrode in which the AP potential was recorded resulted in a stimulus-ventricle interval identical to the AP-ventricle interval during antegrade conduction, and a stimulus-atrium interval identical to the AP-atrium interval during retrograde conduction. With the patient in the drug-free state, antegrade AP block during atrial pacing and retrograde AP block during ventricular pacing occurred distal to the AP potential (AP-ventricle junction and AP-atrium junction, respectively), supporting the "impedance mismatch" hypothesis. Procainamide and disopyramide each lengthened the antegrade AP effective refractory period by affecting the AP-ventricle junction (possibly by decreasing the current generated by the AP). Both drugs also lengthened the retrograde AP effective refractory period but produced a greater effect on the ventricle-AP junction than on the AP-atrium junction, suggesting marginal geometry of the former. R wave synchronous shocks of 160 and 320 W-sec delivered between the catheter electrode recording the largest unipolar AP potential and a skin electrode produced transient, complete, antegrade block over the AP, suggesting the feasibility of this new nonsurgical technique for AP ablation. Circulation 68, No. 5, 906-916, 1983. OUR UNDERSTANDING of the electrophysiologic properties of accessory atrioventricular pathways (APs) and their atrial and ventricular connections has been limited by the inability to record activation directly from the accessory pathway. Electrical potentials consistent with AP activation have been recorded rarely in man by epicardial electrodes during surgery' and by endocardial catheter electrodes,2 I but these reports contain little information regarding the properties of conduction and the sites of antegrade and retrograde block. We were able to directly record AP activation in one patient during serial electrophysiologic studies. This report describes the conduction and refractory properties of the accessory pathway and its atrial and ventricular connections, including the site of antegrade 
Circulation 68, No. 5, 906-916, 1983. OUR UNDERSTANDING of the electrophysiologic properties of accessory atrioventricular pathways (APs) and their atrial and ventricular connections has been limited by the inability to record activation directly from the accessory pathway. Electrical potentials consistent with AP activation have been recorded rarely in man by epicardial electrodes during surgery' and by endocardial catheter electrodes,2 I but these reports contain little information regarding the properties of conduction and the sites of antegrade and retrograde block. We were able to directly record AP activation in one patient during serial electrophysiologic studies. This report describes the conduction and refractory properties of the accessory pathway and its atrial and ventricular connections, including the site of antegrade and retrograde block, the effect of antiarrhythmic drugs on those properties, and an attempt to nonsurgically ablate the AP by delivering high-energy shocks through the catheter electrode.
Methods and results
The patient is a 32-year-old woman with Ebstein's anomaly and Wolff-Parkinson-White syndrome (figure 1). She presented with a 10 year history of episodic palpitations, up to 4 hr in duration, occasionally associated with near-syncope. Electrophysiologic study verified the presence of ventricular preexcitation with the delta wave directed positively in electrocardiographic (ECG) leads I and VI, and negatively in leads II and III.
Retrograde atrial activation was recorded earliest in the right posterior septal region. Programmed electrical stimulation induced sustained atrioventricular (AV) reentrant tachycardia using the AP for retrograde conduction (cycle length 380 msec), sustained atrial fibrillation with AV conduction occurring almost exclusively over the AP (shortest R-R interval = 250 msec; mean R-R interval = 340 msec), and sustained ventricular tachycardia (cycle length 250 msec). Serial electrophysiologic studies were performed during oral therapy with quinidine PATHOPHYSIOLOGY AND NATURAL HISTORY-ELECTROPHYSIOLOGY Vt -.
i--FIGURE 1. ECG during sinus rhythm revealing delta wave (arrows) directed positively in lead I, aVL, and the right precordial leads and directed negatively in 11, III, and aVF, consistent with a posterior septal accessory AV pathway. P-R (delta) interval = 0.16 sec.
mide, 200 mg every 6 hr (serum level unavailable), each in combination with propranolol, 100 mg every 6 hr. Each of these drug regimens prevented the induction of AV reentrant tachycardia or allowed only nonsustained tachycardia and produced a satisfactory increase in antegrade AP refractoriness but facilitated the induction of ventricular tachycardia. During Electrophysiologic data. The electrical potential between the atrial and ventricular potentials recorded endocardially at the right posterior septal AV junction is denoted in all figures by AP, since it possibly represents accessory AV pathway activation. In the drug-free state the AP potential measured 0.95 mV (unfiltered), followed local atrial activation (onset of the first rapid atrial deflection in the electrogram recording the AP potential) by 45 msec, and preceded ventricular activation by 45 msec (figure 3). Ventricular activation was detected earliest in the bipolar electrogram that recorded the AP potential and preceded the onset of the delta wave on the surface ECG by 15 msec (figure 3).
During decremental high right atrial pacing, the A-H interval lengthened progressively as the pacing cycle length was shortened (figure 4). This was associated with a progressive increase in the degree of ventricular preexcitation. The initial forces of the fully preexcited complexes were weakly positive in ECG leads I and VI and negative in leads II and III, consistent with excitation from a posterior septal AV pathway. The interval from the AP potential to the onset of ventricular activation remained relatively constant (50 to 55 msec) until block occurred distal to the AP potential. The interval from pacing stimulus to ventricular activation increased progressively from 180 to 235 msec, primarily due to a 40 msec increase in the interval from local atrial activation to the AP potential. This was associated with a decrease in amplitude of the atrial electrogram.
Similar findings were observed during atrial extrastimulus testing (figure 5). At critically short AP1-AP2 intervals, antegrade block over the AP occurred distal to the AP potential, initiating AV reentrant tachycardia using the AP for retrograde conduction. Retrograde atrial activation was recorded earliest in the AP electrogram and was followed serially by atrial activation in the His bundle electrogram and high right atrial electrogram. The AP potential preceded retrograde atrial activation by 40 msec, and this relationship remained constant during preexcitation of the atrium by a paced premature ventricular depolarization (figure 6). These findings exclude the possibility that the AP potential represents fragmented or delayed atrial activation, leaving only AP activation or ventricular activation in the immediate vicinity of the AP as possible origins.
Evidence that the AP deflection does not represent fragmented or late ventricular activation is shown in figure 7 . High right atrial pacing at a cycle length of 330 msec was instituted during AV reentrant tachycardia. The atrium in the region of the accessory pathway was captured antegradely by the last two pacing stimuli (lower unfilled arrows). Note that when atrial activation precedes ventricular activation at the site of the accessory pathway, the ventricular electrogram is not followed by the AP deflection (upper unfilled arrow), and the tachycardia terminates. If the AP deflection represented fragmented or late ventricular activation, the deflection should have remained, since the QRS morphology was unchanged.
Our ability to selectively pace the AP from the bipolar ( During decremental right ventricular pacing with the patient in the drug-free state, the intervals from local ventricular activation (onset of the first rapid ventricular deflection in the AP electrogram) to AP potential and from AP potential to retrograde atrial activation remained relatively constant and were similar to the AP-V and A-AP intervals, respectively, during sinus rhythm (figure 9). Retrograde block occurred distal to the AP potential at a pacing cycle length of 320 msec after a significant decrement in AP potential amplitude. It is unlikely that retrograde accessory pathway block resulted from atrial refractoriness because the atrium could be activated retrogradely during ventricular extrastimulus testing (pacing cycle length of 500 msec) to AP1-AP2 intervals less than or equal to 300 msec (table   1) , and the atrial effective refractory period is expected to be longer at a cycle length of 500 msec than at a cycle length of 320 msec.
Vol. 68, No. 5, November 1983 Disopyramide plus propranolol lengthened antegrade and retrograde conduction times across the AP, whereas these values were essentially unchanged by procainamide plus propranolol (table 1) . Both drug regimens lengthened the antegrade effective refractory period of the AP, facilitating block distal to the AP potential (figure 10). Both drug regimens also markedly lengthened the retrograde effective refractory period of the AP but changed the site of retrograde block from between the AP potential and atrium (distal to AP potential) to between the ventricular electrogram and AP potential (proximal to AP potential, figures 10 and 11).
A shock of 30 W-sec delivered through the catheter electrode recording the largest unipolar AP potential had no effect, while dilutes the relatively small current generated by the strand ("impedance mismatch"). The reduced current is then insufficient to excite the larger muscle mass. With our patient in the drug-free state, both antegrade and retrograde block occurred at or near the insertion of the AP into the larger muscle mass (distal to the AP potential), which supports this hypothesis. Procainamide and disopyramide lengthened antegrade "refractoriness" of the AP-ventricular muscle connection, possibly by decreasing the current generated by the AP, thereby reducing the margin of safety for excitation of the larger muscle mass. This is supported by the decreased voltage of the AP potential during disopyramide therapy (table 1) . Surprisingly, in the retrograde direction, those same drugs had a more pronounced effect on the ventricular muscle-AP junction than on the AP-atrial muscle junction. The mechanism of this latter response is unclear unless the geometry of the All values in milliseconds unless otherwise specified. 
